Levobunolol

Levobunolol is a cyclic ketone that is 3,4-dihydronaphthalen-1-one substituted at position 5 by a 3-(tert-butylamino)-2-hydroxypropoxy group (the S-enantiomer). A non-selective beta-adrenergic antagonist used (as its hydrochloride salt) for treatment of glaucoma. Among its listed roles, it functions as a antiglaucoma drug and a beta-adrenergic antagonist. It is a propanolamine, a cyclic ketone and an aromatic ether. It is the conjugate base of levobunolol(1+). It is derived from a hydride of a tetralin. It is grouped under the following drug class(es): Beta blockers and Ophthalmic beta-blockers. Its therapeutic use is listed as ophthalmic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Levobunololum and Novo Levobunolol. Its PubChem CID is 39468.